Article Details
Retrieved on: 2024-09-06 14:06:58
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Larimar Therapeutics, a clinical-stage biotechnology company listed on NASDAQ, that has received positive ratings from various equity analysts. This ties in with the tags related to stock market metrics, particularly equity securities and options.
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here